Orthofix Medical (OFIX)
(Delayed Data from NSDQ)
$16.21 USD
-0.09 (-0.55%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $16.19 -0.02 (-0.12%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth B Momentum C VGM
Cash flow Statements
Fiscal Year End for ORTHOFIX MEDICAL INC falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -151.40 | -19.75 | -38.38 | 2.52 | -28.46 |
Depreciation/Amortization & Depletion | 96.61 | 32.08 | 44.85 | 34.28 | 28.48 |
Net Change from Assets/Liabilities | -53.96 | -29.24 | -24.70 | 19.70 | -29.38 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 63.00 | 5.37 | 36.70 | 17.78 | 61.40 |
Net Cash From Operating Activities | -45.75 | -11.54 | 18.48 | 74.27 | 32.03 |
Property & Equipment | -62.05 | -24.53 | -19.59 | -24.33 | -22.92 |
Acquisition/ Disposition of Subsidiaries | 29.42 | 0.00 | -1.25 | -18.00 | 0.00 |
Investments | 0.00 | 0.00 | -2.17 | -10.00 | 0.00 |
Other Investing Activities | -0.50 | -1.80 | -1.81 | -1.61 | -1.53 |
Net Cash from Investing Activities | -33.13 | -24.53 | -23.01 | -52.33 | -22.92 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 5.13 | 4.34 | 8.82 | 7.60 | 11.55 |
Issuance (Repayment) of Debt | -27.55 | -2.59 | -0.54 | -0.32 | -0.37 |
Increase (Decrease) Short-Term Debt | 95.50 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -7.75 | -1.82 | -11.91 | -4.03 | -21.87 |
Net Cash from Financing Activities | 65.32 | -0.08 | -3.62 | 3.25 | -10.69 |
Effect of Exchange Rate Changes | 0.62 | -1.00 | -0.82 | 1.24 | -0.21 |
Net Change In Cash & Equivalents | -12.94 | -37.15 | -8.97 | 26.42 | -1.79 |
Cash at Beginning of Period | 50.70 | 87.85 | 96.82 | 70.40 | 72.19 |
Cash at End of Period | 37.76 | 50.70 | 87.85 | 96.82 | 70.40 |
Diluted Net EPS | -4.12 | -0.98 | -1.95 | 0.13 | -1.51 |
Fiscal Year End for ORTHOFIX MEDICAL INC falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -69.46 | -36.02 | -151.40 | -129.22 | -100.36 |
Depreciation/Amortization & Depletion | 37.97 | 19.39 | 96.61 | 72.61 | 50.40 |
Net Change from Assets/Liabilities | -22.25 | -21.32 | -53.96 | -39.54 | -32.04 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 44.13 | 19.36 | 63.00 | 57.10 | 42.46 |
Net Cash From Operating Activities | -9.61 | -18.60 | -45.75 | -39.06 | -39.54 |
Property & Equipment | -19.89 | -10.82 | -62.05 | -47.00 | -24.65 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 29.42 | 29.42 | 29.42 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.70 | -0.05 | -0.50 | -0.50 | -0.50 |
Net Cash from Investing Activities | -20.58 | -10.87 | -33.13 | -18.08 | 4.27 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 3.19 | 0.00 | 5.13 | 2.38 | 2.38 |
Issuance (Repayment) of Debt | -0.35 | -0.17 | -27.55 | -0.48 | -0.32 |
Increase (Decrease) Short-Term Debt | 25.00 | 25.00 | 95.50 | 70.00 | 51.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -6.17 | -3.38 | -7.75 | -31.85 | -31.27 |
Net Cash from Financing Activities | 21.68 | 21.45 | 65.32 | 40.04 | 21.79 |
Effect of Exchange Rate Changes | -0.38 | -0.28 | 0.62 | 0.06 | 0.39 |
Net Change In Cash & Equivalents | -8.89 | -8.29 | -12.94 | -17.04 | -13.09 |
Cash at Beginning of Period | 37.76 | 37.76 | 50.70 | 50.70 | 50.70 |
Cash at End of Period | 28.87 | 29.46 | 37.76 | 33.66 | 37.61 |
Diluted Net EPS | -0.88 | -0.95 | -0.57 | -0.77 | -1.07 |